Neuralink has achieved a significant milestone in neurosurgery by successfully inserting ultra-thin electrode threads directly through the dura mater, the protective membrane surrounding the brain, without performing a traditional incision. This advancement, confirmed by Elon Musk on June 30, 2026, marks a shift in how brain-computer interfaces (BCIs) are deployed.
Traditionally, implanting electrodes requires a durectomy—slicing through the tough, leathery dura mater. This process inherently carries risks of infection and necessitates longer recovery periods. Neuralink’s new approach utilizes a specialized robotic system to push polyimide-based threads, which are thinner than a human hair, through the intact membrane and into the cerebral cortex. The robotic system is specifically programmed to avoid blood vessels during the insertion process.
The threads interface with the company’s N1 device, a coin-sized implant that sits flush against the skull, housing roughly 1,000 electrodes. By leaving the dura mater intact, the company aims to minimize surgical trauma and reduce the overall infection window. This technique positions Neuralink as a middle ground in the BCI landscape: while more invasive than the vascular approach used by competitors like Synchron—which navigates electrodes through blood vessels—it is significantly less invasive than standard direct-implant procedures.
Neuralink’s ongoing clinical trials remain focused on treating paralysis and neurological conditions, including ALS and spinal cord injuries. As a private entity, Neuralink does not offer public shares, and the company confirmed that this development does not involve blockchain or decentralized protocols.